Berhanu R, Schnippel K, Mohr E, Hirasen K, Evans D, Rosen S, Sanne I.  Early Outcomes of Decentralised Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa:  An Observational Cohort Study.  PLoS One, November 2016, 11(11), 1-14.

Brennan AT, Bonawitz R, Gill CJ, Thea DM, Kleinman M, Useem J, Garrison L, Ceccarelli R, Udokwu C, Long L, Fox MP.  A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children.  AIDS 2016, September, 30(15): 2351-2360.  PMID: 27456985

Brennan AT, Bonawitz R, Schnippel K, Berhanu R, Maskew M, Long L, Bassett J, Sanne I, Fox MPIncident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa. Int J Tuberc Lung Dis. 2016 Aug;20(8):1040-5. doi: 10.5588/ijtld.15.0488.  Pubmed PMID: 27393537.

Brennan AT, Long L, Useem J, Garrison L, Fox MP.  Mortality in the First 3 Months on Antiretroviral Therapy Among HIV-Positive Adults in Low-and Middle-Income Countries: A Meta-Analysis.  JAIDS, November, 73(1): 1-10.  PubMed PMID: 27513571.

Budgell EP, Evans D, Schnippel K, Ive P, Long L and Rosen S.  Outcomes of treatment of drug-susceptible tuberculosis at public sector primary healthcare clinics in Johannesburg, South Africa: A retrospective cohort study.  SAMJ, October 2016, 106(10): 1002-1009.  PMID: 27725021.

Castillo-Mancilla JR, Aquilante CL, Wempe MF, Smeaton LM, Firnhaber C, LaRosa AM, Kumarasamy N, Andrade A, Baheti G, Fletcher CV, Campbell TB, Haas DW, MaWhinney S, Anderson PL. Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342). J Antimicrob Chemother. 2016 Jun;71(6):1609-18. doi: 10.1093/jac/dkw005. Epub 2016 Feb 17. PubMed PMID: 26892777.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Cottle L, Zhang XC, Makhema J, Mills LA, Panchia R, Faesen S, Eron J, Gallant J, Havlir D, Swindells S, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano DD, Essex M, Hudelson SE, Redd AD, Fleming TR; HPTN 052 Study TeamAntiretroviral Therapy for the Prevention of HIV-1 Transmission.  N Engl J Med. 2016 Sep 1;375(9):830-9. doi: 10.1056/NEJMoa1600693. PubMed PMID: 27424812.

De Waal R, Cohen K, Fox MP, Stinson K, Maartens G, Boulle A, Davies M-A.  Clinical compliance with laboratory monitoring and prescribing guidelines in HIV 1-infected patients receiving Tenofovir.  SAMJ, April 2016, 106(4), 369-371.  PMID: 27032851.

Evans D, Berhanu R, Moyo F, Nguweneza A, Long L, Fox MPCan Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa. AIDS Behav.  2016 Nov;20(11):2717-2728.  PubMed PMID: 27146828.

Firnhaber C, Goeieman B, Faesen M, Levin S, Williams S, Rameotshela S, Swarts A, Michelow P, Omar T, Williamson AL, Allan B, Schnippel K, Smith JS.  Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.  PLoS One 2016, 11(1): e0144905.doi: 10.1371/journal.pone.0144905. eCollection 2016; PMID:26730710

Fogel JM, Hudelson SE, Ou SS, Hart S, Wallis C, Morgado MG, Saravanan S, Tripathy S, Hovind L, Piwowar-Manning E, Sabin D, McCauley M, Gamble T, Zhang XC, Eron JJ, Gallant JE, Kumwenda J, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim J, Badal-Faesen S, Akelo V, Hosseinipour MC, Santos BR, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Mayer KH, Chen YQ, Cohen MS, Eshleman SH. Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial. J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):304-9. doi: 10.1097/QAI.0000000000000951. PubMed PMID: 26859828; PubMed Central PMCID: PMC4911290.

Fox MP, Berhanu R, Steegen K, Firnhaber C, Ive P, Spencer D, Mashamaite S, Sheik S, Jonker I, Howell P, Long L, Evans D. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa. Trop Med Int Health. 2016 Sep;21(9):1131-7. doi: 10.1111/tmi.12741. Epub 2016 Jul 7. PubMed PMID: 27383454.

Fox MP, Rosen S, Geldsetzer P, Barnighausen T, Negussie E, Beanland R.  Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness.  Journal of Int AIDS Soc.  August 2016, 19:20888: 1-14.  PMID: 27507249.

Gajee R, Schnippel K, Mthupha N, Muzah B, Berhanu RH.  Missed appointments among rifampicin-resistant tuberculosis (RR-TB) patients at a decentralised RR-TB outpatient clinic in Johannesburg, South Africa.  SAMJ, September 2016, 106(9), 912-917

Gama E, Madan J, Langley I, Girma M, Evans D, Rosen S, Squire SB.  Economic Evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multi-drug resistant tuberculosis (STREAM): study protocol.  BMJ Open September 2016, 6(10)-014386, 1-7.

Gous NM, Scott LE, Potgieter J, Ntabeni L, Sanne I, Stevens WS. Implementation and Operational Research: Implementation of Multiple Point-of-Care Testing in 2 HIV Antiretroviral Treatment Clinics in South Africa. J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):e34-43. doi: 10.1097/QAI.0000000000000872. PubMed PMID: 26484742.

Holmes CB, Sanne IChanging models of care to improve progression through the HIV treatment cascade in different populations. Curr Opin HIV AIDS. 2015 Nov;10(6):447-50. doi: 10.1097/COH.0000000000000194. PubMed PMID: 26352397.

Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, Kirui FK, Badal-Faesen S, Lagat D, Nyirenda M, Naidoo K, Hakim J, Mugyenyi P, Henostroza G, Leger PD, Lama JR, Mohapi L, Alave J, Mave V, Veloso VG, Pillay S, Kumarasamy N, Bao J, Hogg E, Jones L, Zolopa A, Kumwenda J, Gupta A; Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial. Lancet. 2016 Mar 19;387(10024):1198-209. doi: 10.1016/S0140-6736(16)00546-8. PubMed PMID: 27025337; PubMed Central PMCID: PMC4931281.

Johnson L, Chiu C, Myer L, Davies MA, Dorrington R, Bekker LG, Boulle A, Meyer-Rath G.  Prospects for HIV control in South Africa: a model-based analysis.  Global Health Action, June 2016, 9: 30314.

Johnson L, Keiser O, Fox MP, Tanser F, Cornell M, Hoffmann CJ, Prozesky H, Boulle A, Davies MA.  Life expectancy trends in adults on antiretroviral treatment in South Africa.  AIDS 2016, 30(16):2545-2550.  PMID:27428744

Katumba AC, reji E, Gitau T, Firnhaber C. World Health Organisation staging, adherence to HAART and abnormal cervical smears amongst HIV-infected women attending a government hospital in Johannesburg, South Africa.  South African Journal of Infectious Diseases 2016, 31(4):112-118.

La Rosa AM, Harrison LJ, Taiwo B, Wallis CL, Zheng L, Kim P, Kumarasamy N, Hosseinipour MC, Jarocki B, Mellors JW, Collier AC; ACTG A5273 Study GroupRaltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study. Lancet HIV. 2016 Jun;3(6):e247-58. doi: 10.1016/S2352-3018(16)30011-X. Epub 2016 Apr 18. PubMed PMID: 27240787; PubMed Central PMCID: PMC4914044.

Lecher S, Williams J, Fonjungo PN, Kim AA, Ellenberger D, Zhang G, Adje TOure C, Agolory S, Appiah-Pippim G, Beard S, Borget MY, Carmona S, Chipunga G, Diallo K, Downer M, Edgil D, Haberman H, Hurlston M, Jadzak S, Kiyaga C, MacLeod W, Makumb B, Muttai H, Mwangi C, Mwangi JW, Mwasekaga, Naluguza M, Ng’Áng’Á LW, Nguyen S, Sawadogo S, Sleeman K, Stevens W, Kuritsky J, Hader S, Nkengasong J.  Progress with Scale-Up of HIV Viral Load Monitoring – Seven Sub Saharan African Countries, January 2015 – June 2016.  Morbidity and Mortality Weekly Report, December 2016, 65(47); 1332-1335.

Lince-Deroche N, Harries J, Mullick S, Mulongo M, Sinanovic E, Pleaners M, Morroni C, Firnhaber C, Holele P.  Achieving universal access to sexual and reproductive health services: the potential and pitfalls of contraceptive services in South Africa. Chapter 9, South African Health Review 2016.

Long LC, Fox MP, Sauls C, Evans D, Sanne I, Rosen SBThe High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa. PLoS One. February 2016 17;11(2):e0148546. doi: 10.1371/ journal.pone.0148546. eCollection 2016. PubMed PMID: 26885977.

Long LC, Rosen SB, Brennan A, Moyo F, Sauls C, Evans D, Modi SL, Sanne I, Fox MP.  Treatments Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa.  PLoS One, December 2016; 11(12), 1-12.  PMC5152901

Luetkemeyer AF, Firnhaber C, Kendall MA, Wu X, Mazurek GH, Benator DA, Arduino R, Fernandez M, Guy E, Johnson P, Metchock B, Sattler F, Telzak E, Wang YF, Weiner M, Swindells S, Sanne IM, Havlir DV, Grinsztejn B, Alland D; AIDS Clinical Trials Group A5295 and Tuberculosis Trials Consortium Study 34 Teams. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings. Clin Infect Dis. 2016 May 1;62(9):1081-8. doi: 10.1093/cid/ciw035. Epub 2016 Feb 2. PubMed PMID: 26839383; PubMed Central PMCID: PMC4826450.

Makura C, Schnippel K, Michelow P, Chibwesha C, Goeieman B, Jordaan S, Firnhaber C.  Choropleth Mapping of Cervical Cancer Screening in South African Using Healthcare Facility-level Data from the National Laboratory Network.  AIMS Public Health Journal, October 2016, 3(4), 849-862.

Mathad JS, Gupte N, Balagopal A, Asmuth D, Hakim J, Santos B, Riviere C, Hosseinipour M, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Mwelase N, Pawar J, Berendes S, Kumarasamy N, Andrade BB, Campbell TB, Currier JS, Cohn SE, Gupta A; New Work Concept Sheet 319 and AIDS Clinical Trials Group A5175 (PEARLS) Study Teams. Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation. J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):123-9. doi: 10.1097/QAI.0000000000001095. PubMed PMID: 27258230; PubMed Central PMCID: PMC5023467.

Maughan-Brown B, Lloyd N, Bor J, Venkataramani AS.  Changes in self-reported HIV testing during South Africa’s 2010/2011 national testing campaign: gains and shortfalls.  Journal of the International AIDS Society, April 2016, 19: 20658; 1-10-.

Mave V, Erlandson KM, Gupte N, Balagopal A, Asmuth DM, Campbell TB, Smeaton L, Kumarasamy N, Hakim J, Santos B, Riviere C, Hosseinipour MC, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Tripathy S, Mwelase N, Berendes S, Andrade BB, Thomas DL, Bollinger RC, Gupta A; ACTG PEARLS and NWCS 319 Study Team. Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults. J Infect Dis. 2016 Jul 1;214(1):65-72. doi: 10.1093/infdis/jiw096. Epub 2016 Mar 8. PubMed PMID: 26962236; PubMed Central PMCID: PMC4907416.

Michelow P, Performance of the Cellslide automated liquid-based cytology system amongst HIV-positive women.  African Journal of Laboratory Medicine, February 2016, 5(1), 1-6

Mokhele I, Evans D, Schnippel K, Swarts A, Smith JC, FIrnhaber C.  Awareness, perceived risk and practices related to cervical cancer and Pap smear screening: A cross-sectional study among HIV-positive women attending an urban HIV clinic in Johannesburg, South Africa.  SAMJ December 2016; 106(12), 1247-1253. PMID:27917772.

Moyo F, Chasela C, Brennan AT, Ebrahim O, Sanne IM, Long L, Evans DTreatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa. Clin Epidemiol. 2016 Mar 18;8:37-47. doi: 10.2147/CLEP.S93014. eCollection 2016. PubMed PMID: 27051316;

Musselwhite LW, Andrade BB, Ellenberg SS, Tierney A, Belaunzaran-Zamudio PF, Rupert A, Lederman MM, Sanne I, Sierra Madero JG, Sereti I. Vitamin D, D-dimer, Interferon γ, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International Study. EBioMedicine. 2016 Jan 14;4:115-23. doi: 10.1016/j.ebiom.2016.01.016. eCollection 2016 Feb. PubMed PMID: 26981576; PubMed Central PMCID: PMC4776072.

Pandie M, Wiesner L, McIlleron H, Hughes J, Siwendu S, Conradie F, Variava E, Maartens G. Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB. J Antimicrob Chemother. 2016 Apr;71(4):1037-40. doi: 10.1093/jac/dkv447. Epub 2016 Jan 7. PubMed PMID: 26747099.
Pappasavvas E, Surrey L, Glencross DK, Azzoni L, Joseph J, Omar T, Feldman MD, Williamson AL, Siminya M, Swarts A, Yin X, Liu Q, Firnhaber C, Montaner L. High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women.  OncoImmunology 2016, 5(5): 1-21.  PMC4910732.

Patro SC, Azzoni L, Joseph J, Fair MG, Sierra-Madero JG, Rassool MS, Sanne I, Montaner LJ. Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation. J Leukoc Biol. 2016 Jul;100(1):223-31. doi: 10.1189/jlb.5AB0915-406R. Epub 2015 Nov 25. PubMed PMID: 26609048; PubMed Central PMCID: PMC4946615.

Robertson K, Jiang H, Evans SR, Marra CM, Berzins B, Hakim J, Sacktor N, Silva MT, Campbell TB, Nair A, Schouten J; 5271 study team, Kumwenda J, Supparatpinyo K, Tripathy S, Kumarasamy N, la Rosa A, Montano S, Mwafongo A, Firnhaber C, Sanne I, Naini L, Amod F, Walawander A; AIDS Clinical Trials Group. International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. J Neurovirol. 2016 Aug;22(4):472-8. doi: 10.1007/s13365-015-0415-2. Epub 2016 Jan 5. PubMed PMID: 26733457; PubMed Central PMCID: PMC4981921.

Rohr JK, Ive P, Horsburgh CR, Berhanu R, Shearer K, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O, Fox MPMarginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa. PLoS One. 2016 Aug 22;11(8):e0161469. doi: 10.1371/journal.pone.0161469. eCollection 2016. PubMed PMID: 27548695; PubMed Central PMCID: PMC4993510.

Rosen S, Fox M, Larson B, Sow PS, Ehrenkranz PD, Venter F, Manabe Y, Kaplan J, MATI Technical Consultation.  Accelerating the Uptake and Timing of Antiuretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda.  PLOS Medicine, 2016 August 9, 13(8): 1-13.

Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, Sanne I, Bokaba D, Sauls C, Rohr J, Long LInitiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial.  PLoS Med. 2016 May 10;13(5):e1002015. doi: 10.1371/journal.pmed.1002015. eCollection 2016 May. Erratum in: PLoS Med. 2016 Jun;13(6):e1002050. PubMed PMID: 27163694; PubMed Central PMCID: PMC4862681.

Saharia KK, Petrovas C, Ferrando-Martinez S, Leal M, Luque R, Ive P, Luetkemeyer A, Havlir D, Koup RA. Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells. PLoS One. 2016 Jul 1;11(7):e0158262. doi: 10.1371/journal.pone.0158262. eCollection 2016. PubMed PMID: 27367521.

Schwartz SR, West N, Phofa R, Yende N, Sanne I, Bassett J, Van Rie A. Acceptability and preferences for safer conception HIV prevention strategies: a qualitative study. Int J STD AIDS. 2016 Oct;27(11):984-92. doi: 10.1177/0956462415604091. Epub 2015 Sep 18. PubMed PMID: 26384950; PubMed Central PMCID: PMC4889551.

Shearer K, Clouse K, Meyer-Rath G, MacLeod W, Maskew M, Sanne I, LongL, Fox MF.  Citizenship status and engagement in HIV care: an observational cohort study to assess the association between reporting a national ID number and retention in public-sector HIV care in Johannesburg, South Africa.  BMJ Open 2017, 7:e013908; 1-8.

Shivakoti R, Yang WT, Berendes S, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Lama JR, Cardoso SW, Sugandhavesa P, Balagopal A, Gupte N, Semba RD, Campbell TB, Bollinger RC, Gupta A; NWCS 319 and PEARLS Study Team. Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings. J Infect Dis. 2016 Apr 1;213(7):1074-8. doi: 10.1093/infdis/jiv573. Epub 2015 Nov 29. PubMed PMID: 26621909; PubMed Central PMCID: PMC4779305.

Singini I, Campbell TB, Smeaton LM, Kumarasamy N, La Rosa A, Taejareonkul S, Safren SA, Flanigan TP, Hakim JG, Hughes MD; ACTG A5175/PEARLS Study Team.Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy. HIV Clin Trials. 2016 Jul 29:1-8. [Epub ahead of print] PubMed PMID: 27472067.

van Vuren J P, Grobbelaar A, Storm N, Conteh O, Konneh K, Kamara A, Sanne I,    Paweska J, Comparative Evaluation of the Diagnostic Performance of the Prototype Cepheid GeneXpert Ebola Assay.  Journal of Clinical Microbiology, February 2016, 54:2; 359-367.  PMCID: PMC4733181

West N, Schwartz S, Phofa R, Yende N, Bassett J, Sanne I, Van Rie A. “I don’t know if this is right … but this is what I’m offering”: healthcare provider knowledge, practice, and attitudes towards safer conception for HIV-affected couples in the context of Southern African guidelines. AIDS Care. 2016;28(3):390-6. doi: 10.1080/09540121.2015.1093596. Epub 2015 Oct 7. PubMed PMID: 26445035; PubMed Central PMCID: PMC4882088.